21 May 2009
Monitoring of microchimerism and anti-hla antibodies in the first polish recipient of hand transplantation in the early post-transplantation period
W Niepiekło, A Chełmoński, M Kamińska, J Jabłecki, D Patrzałek, B NowakowskaAnn Transplant 2009; 14(1): 68-68 :: ID: 880451
Abstract
Background: The hand transplant consists of different tissues of varying immunogenetic potential. Donor's cells can contribute to either rejection or tolerance of the graft. The aim of our study was monitoring of anti-HLA antibodies, a mark of humoral rejection, and microchimerism (induction of donor specific tolerance?) in the first 3 months after transplantation.
Material/Methods: The recipient was 34 year old man with blood group A- positive; HLA-phenotype A24; B18, 60; DRB1*11. Multi organ cadaveric donor was 41 year-old man blood group A-positive; HLA-phenotype A 31,32; B 35, 39; DRB1*11,16, negative T- and B-cell cross-match. We examined recipient's blood and sera specimens, obtained 1 and 2 weeks, and 1, 2 and 3 months after transplantation. Anti-HLA antibodies were monitored by the complement-dependent cytotoxicity assay (CDC), with prolonged time of incubation, with PBL and B lymphocyte. Microchimerism was analyzed using nested polymerase chain reaction with sequence specific primers typing methods (nested
PCR-SSP) for detection of HLA-A alleles.
Results: No anti-HLA alloantibodies were detected in the study period, what
confirmes that humoral rejection occurs rarely, if at all, in the human composite tissue allografts. Peripheral microchimerism was observed in all tested specimens. It is still debated whether this microchimerism can induce tolerance or is it only a side effect of transplantation.
Keywords: composite tissue transplantation, Limb Transplantation
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860